Femme et Homme
- | Pays :
- United States
- France
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of AG-881 in advanced hematologic malignancies that harbor an IDH1 and/or IDH2 mutation
Critère d'inclusion
- Acute Myeloid Leukemia (AML) ,myelodysplastic syndrome ,hematologic malignancies